Amino Health vs Humane Genomics
Side-by-side comparison of AI visibility scores, market position, and capabilities
Amino Health provides a data-driven healthcare navigation platform that helps employees find high-quality, in-network providers using a 26B+ claims database; raised $70M+ total;
About
Amino Health is a digital health company founded in 2013 and headquartered in San Francisco, California, that helps employees and health plan members find high-quality, cost-effective in-network healthcare providers using data-driven recommendations. The platform is powered by a proprietary database of more than 26 billion de-identified medical claims, which enables Amino to estimate physician quality, specialty expertise, and patient cost outcomes based on actual historical treatment data rather than self-reported information or generic star ratings.
Synthetic oncolytic virus biotech engineering programmable cancer-killing RNA viruses; $8.12M raised with Union Square Ventures leading 2025 round competing in cancer immunotherapy.
About
Humane Genomics is a synthetic virology biotech company engineering oncolytic viruses — synthetic RNA viruses designed to selectively infect and destroy cancer cells while leaving healthy cells unharmed — using a proprietary platform that programs viral behavior at the genomic level to create next-generation cancer therapies. The company raised $8.12 million in total funding including a February 2025 round led by Union Square Ventures with 14 investor participants, developing RNA-based viral cancer therapies for systemic delivery designed for extended therapeutic activity.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.